Literature DB >> 26743052

[Diagnosis of the porphyrias : From A (as in aminolevulinic acid) to Z (as in zinc protoporphyrin)].

V Kürten1, N J Neumann1, J Frank2.   

Abstract

The porphyrias comprise a clinically, biochemically, and genetically heterogeneous group of predominantly hereditary metabolic disorders resulting from a dysfunction along the heme biosynthetic pathway. Whereas most variants can manifest with different cutaneous symptoms, some types only reveal life-threatening acute neurovisceral attacks. Therefore, interdisciplinary care of these patients is advisable. In this article, we provide an overview of characteristic clinical and laboratory findings in the various forms of porphyria and a diagnostic algorithm.

Entities:  

Keywords:  Blood analysis; Diagnostics, enzyme deficiency; Heme biosynthesis; Stool analysis; Urine analysis

Mesh:

Substances:

Year:  2016        PMID: 26743052     DOI: 10.1007/s00105-015-3741-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  29 in total

1.  C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload.

Authors:  Sharon D Whatley; Sarah Ducamp; Laurent Gouya; Bernard Grandchamp; Carole Beaumont; Michael N Badminton; George H Elder; S Alexander Holme; Alexander V Anstey; Michelle Parker; Anne V Corrigall; Peter N Meissner; Richard J Hift; Joanne T Marsden; Yun Ma; Giorgina Mieli-Vergani; Jean-Charles Deybach; Hervé Puy
Journal:  Am J Hum Genet       Date:  2008-09-04       Impact factor: 11.025

2.  Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases.

Authors:  R P Katugampola; M N Badminton; A Y Finlay; S Whatley; J Woolf; N Mason; J C Deybach; H Puy; C Ged; H de Verneuil; S Hanneken; E Minder; X Schneider-Yin; A V Anstey
Journal:  Br J Dermatol       Date:  2012-09-18       Impact factor: 9.302

3.  A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases.

Authors:  R P Katugampola; A V Anstey; A Y Finlay; S Whatley; J Woolf; N Mason; J C Deybach; H Puy; C Ged; H de Verneuil; S Hanneken; E Minder; X Schneider-Yin; M N Badminton
Journal:  Br J Dermatol       Date:  2012-09-18       Impact factor: 9.302

Review 4.  Porphyrias: A 2015 update.

Authors:  Zoubida Karim; Said Lyoumi; Gael Nicolas; Jean-Charles Deybach; Laurent Gouya; Hervé Puy
Journal:  Clin Res Hepatol Gastroenterol       Date:  2015-07-02       Impact factor: 2.947

5.  A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.

Authors:  A G Roberts; G H Elder; R E De Salamanca; C Herrero; M Lecha; J M Mascaro
Journal:  J Invest Dermatol       Date:  1995-04       Impact factor: 8.551

6.  Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria.

Authors:  M J Moran-Jimenez; C Ged; M Romana; R Enriquez De Salamanca; A Taïeb; G Topi; L D'Alessandro; H de Verneuil
Journal:  Am J Hum Genet       Date:  1996-04       Impact factor: 11.025

7.  Photosensitivity in the elderly-think of late-onset protoporphyria.

Authors:  Jorge Frank; Pamela Poblete-Gutiérrez; Norbert J Neumann
Journal:  J Invest Dermatol       Date:  2013-06       Impact factor: 8.551

Review 8.  Erythropoietic protoporphyria.

Authors:  Mario Lecha; Hervé Puy; Jean-Charles Deybach
Journal:  Orphanet J Rare Dis       Date:  2009-09-10       Impact factor: 4.123

9.  Erythropoietic protoporphyria without skin symptoms-you do not always see what they feel.

Authors:  Anne L Y Lecluse; Veronica C M Kuck-Koot; Huib van Weelden; Vigfus Sigurdsson; Ingrid M Russel; Jorge Frank; Suzanne G M A Pasmans
Journal:  Eur J Pediatr       Date:  2007-08-21       Impact factor: 3.183

Review 10.  An update of clinical management of acute intermittent porphyria.

Authors:  Elena Pischik; Raili Kauppinen
Journal:  Appl Clin Genet       Date:  2015-09-01
View more
  1 in total

Review 1.  [Porphyria cutanea tara].

Authors:  H F Merk
Journal:  Hautarzt       Date:  2016-03       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.